Moderna said on Wednesday it has withdrawn an application seeking approval for its flu and COVID combination vaccine ...

After being hailed as a triumph of public-private drug development, Moderna's partnership with the US government on its COVID-19 vaccine ... Moderna's mRNA-1273 shot. The patent has been filed ...

Moderna voluntarily pressed pause on its request to license its vaccine candidate, mRNA-1083 — which combines vaccines for seasonal influenza and covid and is intended for people over 50 — until it ...

Moderna researchers reported that the combo shot produced a stronger immune response against COVID-19 and most flu ... “I agree in this case with FDA that efficacy data are important to see ...

A combination shot for flu and COVID-19 using messenger RNA generated antibodies in a study, but U.S. government regulators want to see data on whether the new vaccine protects people from getting ...

THURSDAY, May 8, 2025 (HealthDay News) — A new vaccine that combines flu and COVID ... Moderna said it now expects that approval of the shot may not come until 2026. “I agree in this case ...

Researchers from vaccine-maker Moderna reported in a study published Wednesday that the new combo shot generated a stronger immune response against COVID-19 ... agree in this case with FDA that ...